Diamond-like carbon (DLC) is a class of materials with outstanding mechanical, tribological and biological properties. From in-vitro experiments, it is known that by incorporating other elements into the DLC film, the ratios of the different proteins adsorbed on the surface can be changed. These proteins will then subsequently control cell attachment, cell proliferation and cell differentiation.
INTRODUCTION
The implantation of biomaterials into the human body allows it to re-establish biological and mechanical functions and therefore to increase the quality of life. The load bearing properties of the implants are mainly controlled by the bulk properties of the implant whereas the interaction with the surrounding tissue is governed by the implant surface. The implant surface influences in particular the interaction and adsorption of different proteins which, in turn, control the cell adhesion and behavior. For an introduction to biological process at surface see the overview articles by Castner and Ratner [1] and by Kasemo [2] . To create a surface for desired bioreactions, a promising approach is to start from an existing biocompatible coating (to prevent inflammatory reaction or repulsion) and to alloy it with adequate elements. Due to its bio-and haemocompatible nature, there is a growing interest in the application of DLC on orthopedic and other implants. Additionally, DLC is an excellent base coating to be alloyed with different elements. The amorphous nature of DLC opens the possibility to introduce certain amounts of additional elements, such as Si, F, N, O, W, V, Co, Mo or Ti. Today, two main fields of biological applications of DLC can be seen. The application of DLC in blood contacting implants such as heart valves and stents and the use of DLC to reduce wear in load bearing joints. A more detailed overview on DLC for biological applications can be found in [3] . 
CELLS IN CONTACT WITH DLC
Several research groups confirmed the biocompatibility of DLC by growing different cell types in-vitro on DLC and studying the cell response. By varying alloy element concentration in DLC, it is possible to tailor the bioreactions to any desired point between the bio-properties of DLC and those of the added element. In the last years only a few papers present experiments where bioreactions on DLC have been changed by alloying, see overview [3] and references therein.
BLOOD CONTACTING APPILICATIONS
For implants in direct contact with blood, a key issue is the ability of the implant surface to prevent thrombus formation. It is generally known, that increased platelet adhesion, activation and aggregation on implant surfaces exposed to blood precede the formation of a thrombus. Therefore, in-vitro analysis of these properties is usually performed as a first test of the haemocompatibility of a surface. Several papers of in-vitro essays on DLC surfaces indicate that this material may have the ability to suppress thrombus formation similar or even better than glassy carbon, a material widely used for heart valves. Only a few papers present in-vivo results of DLC coated implants. In his Ph.D. thesis [4] , Yang studied the haemocompatibility of different surfaces implanted for two hours into the intrathoracic venae cavae of Swedish native sheep. The results showed that there were significantly more blood platelets on pyrolytic carbon and methylated titanium than on titanium, cobalt-chromium and DLC [4] . A DLC coated centrifugal ventricular blood pump device (made by SunMedical Technology Research Corporation, Nagano, JAPAN) coated with DLC was implanted in calves and, even without post-operative anticoagulation, only minor evidence of thrombosis was found on the DLC coated surfaces after explantation. Due to the good haemocompatibility of DLC, a few companies have DLC coated implants already commercially available or in the state of development. The company Sorin Biomedica produces heart valves and stents which are coated by a so called Carbofilm TM . A clinical study on these coated stents, implanted in 122 patients, resulted in a low restenosis rate of 11% after six month [5] .
HIP JOINTS AND LOAD BEARING IMPLANTS
In prosthetic hip replacements, polyethylene wear debris has been identified as the main factor limiting the lifetime of the implants. Debris from the polymer cup in the joint can induce tissue reactions and bone resorption that may lead to implant loosening.
There are many papers on friction and wear of DLC coated hip joint balls sliding against UHMWPE (ultra high molecular weight polyethylene) using 1wt% NaCl or distilled water as lubricants. Most of them found a decrease in wear of the UHMWPE when sliding against DLC. No significant reduction in the wear of the UHMWPE when sliding against DLC coated femoral heads was reported in all the papers using synovial fluid as a lubricant (see [6] and references therein). The experimental setup and especially the liquid lubricant used in a tribological test, seems to have a crucial influence on the results obtained. It was suggested that when bovine serum or synovial fluid was used as a lubricant, the different proteins, especially phospholipids, adsorbed on the surfaces, strongly influences the tribological behavior in the joints and that also when the protein concentration is to low, the results may show a non-clinically relevant wear morphology.
In the case of a metal /metal joint with both sides coated with DLC, very low wear rates have been reported for all setups and lubricants used, by several research groups [7, 8] . It seems that the situation of DLC sliding against DLC may be different to DLC sliding against UHMWPE. The test performed in aqueous NaCl did lead to very low wear values, comparable to those obtained in bonvine serum, indicating that a similar wear mechanism takes place in both cases. The build up of a transfer layer may not be a key requirement for low wear or may not be severely altered by the presence of proteins.
Teager at al. [9] published data about the clinical failure rate of an eight year follow-up on 101 patients with implanted DLC coated femoral balls articulating against polyethylene. Whereas the DLC coated implants showed no sign of problems within the first 1.5 years, thereafter more and more DLC implants showed aseptic loosening requiring revision (replacement) of the implant. Within 8.5 years 45% of the originally implanted DLC coated joints had to be replaced. The DLC coating on the retrieved joint heads showed numerous mostly round shaped pits. In my opinion, one of the main problems of the DLC films was the long term chemical stability of the DLC/Ti6Al4V interface. When a coating is deposited onto a metallic substrate, usually an about one nanometer thick reaction-layer is formed at the interface, which is responsible for good adhesion. Depending on the precleaning and the conditions at the very beginning of the DLC deposition process, the interface reaction layer consists usually of a metal-carbide, or metal-hydro-oxy-carbide. The long-term chemical stability of this reaction layer has to be guaranteed also under in-vivo conditions. Interface delamination due to interface corrosion involves also residual stress and electrochemical aspects and is not fully understood today.
